At Siddhi Therapeutics, we are building a pipeline of novel and targeted oncology therapies with the potential to serve specific populations of cancer patients.
Our pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of conventional anti-cancer therapies through simultaneous targeting of key drivers of disease in cancer cells without overlapping toxicities and thus preserving the quality of life in cancer patients.
Laboratories in 100+ states
Laboratory specialists
Material collection points
Patients diagnosed in 2022
We have two clinical-stage investigational products for hematologic malignancies.
Clinical Trials :
Testing Begins many varios
suffered alten in some
Testing Begins many varios
suffered alten in some
Testing Begins many varios
suffered alten in some
Exerci tation ullamcorper suscipit lobortis nisl aliquip ex ea commodo claritatem insitamconse quat.Exerci tation ullamcorper suscipit loborti excommodo habent claritatem insitamconse quat.Exerci tationlobortis nisl aliquip ex ea commodo habent claritatem insitamconse quat.
Exerci tation ullamcorper suscipit lobortis nisl aliquip ex ea commodo claritatem insitamconse quat.Exerci tation ullamcorper suscip
Exerci tation ullamcorper suscipit lobortis nisl aliquip ex ea commodo claritatem insitamconse quat.Exerci tation ullamcorper suscipit loborti excommodo habent claritatem insitamconse quat.Exerci tationlobortis nisl aliquip ex ea commodo habent claritatem insitamconse quat.
Exerci tation ullamcorper suscipit lobortis nisl aliquip ex ea commodo claritatem insitamconse quat.Exerci tation ullamcorper suscip